Results 161 to 170 of about 261,105 (346)

Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer

Chinese Journal of Lung Cancer, 2009
Background and objective Second-line chemotherapy with taxanes for the patients with non-small cell lung cancer (NSCLC), who had disease recurrence or failure in previously treated with platinum-based chemotherapy, has been shown to be effective. Besides
Tianqing CHU, Hao LIN, Jie SHEN, Runbo ZHONG, Baohui HAN   +4 more
doaj  

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

, 1998
Mace L. Rothenberg, A. Sharma, Geoffrey R. Weiss, Miguel A. Villalona‐Calero, John R. Eckardt, C. Aylesworth, Maura A. Kraynak, David Rinaldi, Gladys Rodriguez, H. A. Burris, S. Gail Eckhardt, Connie Stephens, Kelly Forral, Steven J. Nicol, Daniel D. Von Hoff   +14 more
openalex   +1 more source

Integrating Metabolic Modulation and Nanomedicine for Cancer Immunotherapy

Advanced Science, EarlyView.
Metabolic rewiring in cancer is mapped across glucose, amino acid, lipid, nucleotide, and mitochondrial pathways, with emphasis on immune regulation. The review integrates mechanisms linking these pathways to tumor progression and therapy resistance, and profiles nanomaterial platforms that both deliver therapeutics and actively reprogram ...
Xiaosu Zhou, Ruibing Deng, Zunde Liao, Xiaoyu Huang, Junting Huang, Hanlou Yang, Kam W. Leong, Yiling Zhong   +7 more
wiley   +1 more source

Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer

, 1997
Olivia Pagani, Cristiana Sessa, Giovanni Martinelli, T. Cerny, J. de Jong, Aron Goldhirsch, Matteo Zimatore, Franco Cavalli   +7 more
openalex   +1 more source

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer [PDF]

, 1996
William P. McGuire, William J. Hoskins, Mark F. Brady, Paul R. Kucera, Edward E. Partridge, Katherine Y. Look, Daniel L. Clarke‐Pearson, Martin Davidson   +7 more
openalex   +1 more source

Mechanotransduction in Shaping Immunity: Pathways, Crosstalk, and Pathophysiological Relevance

Advanced Science, EarlyView.
This review comprehensively summarizes the role of mechanotransduction in shaping immunity. It details how immune cells respond to biomechanical cues via mechanotransduction cascades and emphasizes the mechanical crosstalks within the immune microenvironment. The emerging significance of mechanoimmunology in both health and diseases is also highlighted.
Ruijiao Yan, Yuyu Li, Shuo Chen, Li Zhu, Chenchen Zhou, Jianwei Chen, Shujuan Zou, Xianglong Han   +7 more
wiley   +1 more source

2035 A phase I study of paclitaxel as a radiation sensitizer for the treatment of non-small cell lung cancer and mesothelioma

, 1995
Laurie L. Herscher, S.M. Hahn, Harvey I. Pass, Barbara K. Temeck, Barry R. Goldspiel, J. E. Cook, James B. Mitchell, J. Liehmann   +7 more
openalex   +1 more source

Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy

Annals of Gastroenterological Surgery, EarlyView.
This study investigated the association between radiographic and pathological response assessments among patients with pancreatic cancer receiving neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy. The present study revealed that discrepancies between radiographic and histological responses may differ according to the type of therapy ...
Satoru Miyahara, Hidenori Takahashi, Yoshito Tomimaru, Shogo Kobayashi, Daisaku Yamada, Hirofumi Akita, Takehiro Noda, Yuichiro Doki, Hidetoshi Eguchi   +8 more
wiley   +1 more source

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study [PDF]

, 1995
Stanley P. Balcerzak, Jacqueline Benedetti, Geoffrey R. Weiss, Ronald B. Natale   +3 more
openalex   +1 more source

Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.

Nanomedicine : nanotechnology, biology, and medicine, 2016
M. Kim, Matthew J. Haney, Yuling Zhao, V. Mahajan, I. Deygen, N. Klyachko, Eli Inskoe, A. Piroyan, Marina Sokolsky, Onyi Okolie, Shawn D. Hingtgen, A. Kabanov, E. Batrakova   +12 more
semanticscholar   +1 more source